Article info
PDFTherapeutics
Metformin reduced diabetes-related end points and all-cause mortality in overweight patients with type 2 diabetes
Citation
Metformin reduced diabetes-related end points and all-cause mortality in overweight patients with type 2 diabetes
Online issue publication
February 20, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions